- AVITA Medical press release (NASDAQ:RCEL): Q2 GAAP EPS of -$0.38 misses by $0.12.
- Revenue of $18.42M (+21.2% Y/Y) misses by $4.02M.
-
As a result of slower than expected sales in the first half, significantly compounded by the ongoing reimbursement issue, AVITA has
AVITA Medical GAAP EPS of -$0.38 misses by $0.12, revenue of $18.42M misses by $4.02M

Related
Nu Skin targets $1.48B–$1.55B revenue and $3.05–$3.25 EPS fo...
16 minutes ago
0
Xeris raises 2025 revenue guidance to $280M–$290M following ...
17 minutes ago
0
Akebia outlines access to over 275,000 dialysis patients for...
22 minutes ago
0
Take-Two raises FY26 net bookings outlook to $6.15B as mobil...
30 minutes ago
0
Akamai outlines 40%–45% cloud infrastructure ARR growth targ...
32 minutes ago
0
Onto Innovation anticipates 50% AI packaging revenue surge i...
40 minutes ago
0
Aemetis targets 550,000 MMBtu RNG production capacity in 202...
45 minutes ago
0
Ring Energy signals continued cost reductions and targets $1...
50 minutes ago
0
Occidental's direct air capture hub to step start operations...
58 minutes ago
0
Nextdoor Holdings reports Q2 results
1 hour ago
0
Vroom GAAP EPS of -$1.65, revenue of $41.42M
1 hour ago
0
Saul Centers GAAP EPS of $0.33, revenue of $70.8M
1 hour ago
0
Global Payments declares $0.60 dividend
1 hour ago
0
Twin Disc declares $0.04 dividend
1 hour ago
0
Trending
Popular
اعزام اورژانس هرمزگان به مرز شلمچه
4 days ago
3
© FBT Company 2025. All rights are reserved